•  Retrait gratuit dans votre magasin Club
  •  7.000.000 titres dans notre catalogue
  •  Payer en toute sécurité
  •  Toujours un magasin près de chez vous     
  •  Retrait gratuit dans votre magasin Club
  •  7.000.0000 titres dans notre catalogue
  •  Payer en toute sécurité
  •  Toujours un magasin près de chez vous
  1. Accueil
  2. Livres
  3. Sciences humaines
  4. Sciences
  5. Biologie
  6. Sciences de la vie
  7. Current Challenges in Cell Therapy for Neurodegenerative Diseases

Current Challenges in Cell Therapy for Neurodegenerative Diseases

Volume 166

Livre relié | Anglais | International Review of Neurobiology | n° 166
356,45 €
+ 712 points
Livraison 2 à 3 semaines
Passer une commande en un clic
Payer en toute sécurité
Livraison en Belgique: 3,99 €
Livraison en magasin gratuite

Description

Cell Transplantation and Gene Therapy in Neurodegenerative Disease, Volume 166 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters written by an international board of authors who cover Challenges in translating a cell therapy to GMP, The challenges in developing a cell therapy for Huntington's disease, Challenges of cell therapies for retinal diseases, Challenges of gene therapy in Huntington's Disease, Technological advances and barriers to gene therapy, Considerations in the development of cell therapy modulation for spinal cord injury treatment, Challenges of developing glial cell therapy for ALS, and more.

Other chapters in this comprehensive release include Exploring cell and gene therapy in current animal models of Parkinson's and Huntington's disease, Considerations for the use of biomaterials to support cell therapy in degenerative disease, Neurosurgical challenges/innovations in cell and gene therapy delivery, Neuroimaging: the challenge of harnessing imaging tools to facilitate cell and gene therapy in neurodegenerative diseases/The contribution and challenges for imaging in advanced therapies of movement disorders, Considerations for clinical trial design for novel advanced therapeutics in neurodegenerative disease, and More than a trial participant: The role of the patient in ATMP development and trials for neurodegenerative disease.

Spécifications

Parties prenantes

Editeur:

Contenu

Nombre de pages :
324
Langue:
Anglais
Collection :
Tome:
n° 166

Caractéristiques

EAN:
9780323989374
Date de parution :
16-11-22
Format:
Livre relié
Format numérique:
Genaaid
Dimensions :
152 mm x 229 mm
Poids :
603 g

Les avis

Nous publions uniquement les avis qui respectent les conditions requises. Consultez nos conditions pour les avis.